Xtant Medical Holdings (XTNT) Cash from Financing Activities (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Cash from Financing Activities of -$5.8 million for Q3 2025, down 208.6% year-over-year from $5.3 million in Q3 2024, and down 971.75% quarter-over-quarter from $662000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Cash from Financing Activities for 16 consecutive years, with -$5.8 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cash from Financing Activities fell 208.6% year-over-year to -$5.8 million; the TTM figure through Sep 2025 stood at -$6.9 million (down 139.89% YoY), while the FY2024 annual figure was $16.1 million, down 18.37% from the prior year.
- Cash from Financing Activities eased to -$5.8 million in Q3 2025 per XTNT's latest filing, from $662000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $18.1 million in Q1 2021 and bottomed at -$5.8 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged $3.0 million across 5 years, with a median of $662000.0 in 2025.
- On a YoY basis, Cash from Financing Activities climbed as much as 53311.76% in 2021 and fell as far as 1515.0% in 2021.
- Xtant Medical Holdings' Cash from Financing Activities stood at -$55000.0 in 2021, then surged by 10307.27% to $5.6 million in 2022, then plunged by 94.21% to $325000.0 in 2023, then tumbled by 362.77% to -$854000.0 in 2024, then tumbled by 575.76% to -$5.8 million in 2025.
- Business Quant data shows XTNT's Cash from Financing Activities at -$5.8 million in Q3 2025, $662000.0 in Q2 2025, and -$919000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Xtant Medical Holdings | 46.30 Mn | 28.69 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -5.77 Mn |
| Sep 30, 2025 | -5.77 Mn |
| Jun 30, 2025 | 662,000.00 |
| Jun 30, 2025 | 662,000.00 |
| Mar 31, 2025 | -919,000.00 |
| Mar 31, 2025 | -919,000.00 |
| Dec 31, 2024 | -854,000.00 |
| Dec 31, 2024 | -854,000.00 |
| Sep 30, 2024 | 5.31 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Mar 31, 2024 | 5.18 Mn |
| Mar 31, 2024 | 5.18 Mn |
| Dec 31, 2023 | 325,000.00 |
| Dec 31, 2023 | 325,000.00 |
| Sep 30, 2023 | 12.84 Mn |
| Sep 30, 2023 | 12.84 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.95 Mn |